Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic paravertebral block and chronic pain after breast cancer surgery
ChiCTR-IPR-16008127Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in Persistent postsurgical pain (PPSP) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of postoperative chronic pain. Planned start Apr 2016; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR-IPR-16008127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008127.